TY - JOUR
T1 - Safety of magnetic resonance imaging in patients with permanent pacemakers
T2 - A collaborative clinical approach
AU - Boilson, Barry Anthony
AU - Wokhlu, Anita
AU - Acker, Nancy G.
AU - Felmlee, Joel P.
AU - Watson, Robert E.
AU - Julsrud, Paul R.
AU - Friedman, Paul A.
AU - Cha, Yong Mei
AU - Rea, Robert F.
AU - Hayes, David L.
AU - Shen, Win Kuang
N1 - Funding Information:
Disclosures Dr. Friedman is involved in sponsored research with Medtronic, Boston Scientific, Bard, St. Jude Medical, and Pfizer; has intellectual property rights with Bard EP, Hewlett Packard, Medical Positioning, Inc., Aegis Medical, and NeoChord; and has spoken for and/or consulted for Medtronic, Boston Scientific, and St. Jude Medical. David L. Hayes serves as a member of the advisory board for St. Jude Medical, Boston Scientific. He also serves as a speaker at educational venues for St. Jude Medical, Boston Scientific, Sorin Medical, Biotronik, and Medtronic. Dr. Shen receives funding from Medtronic for an investigator initiated research project.
PY - 2012/1
Y1 - 2012/1
N2 - Objective: This study aimed to characterize the interactions of pacemakers with magnetic resonance imaging (MRI) and to identify device characteristics that could predict adverse interactions. Background: The safety of MRI in patients with indwelling pacemaker systems remains uncertain. Previous studies demonstrated safety in most patients, but unpredictable, potentially concerning changes in pacemaker behavior have occurred. Methods: We prospectively studied patients with pacemaker devices in situ who were not pacemaker dependent and in whom MRI was essential for adequate diagnosis and treatment. All patients were monitored by electrocardiography and pulse oximetry during scanning; devices were interrogated and cardiac enzymes were measured before and after scanning. Results: Of 32 patients studied (46 MRI examinations), 28 patients had a dual-chamber system and one had a biventricular device. Regions scanned were the head and spine. Devices were reprogrammed to asynchronous pacing or sense-only mode in all except six patients beforeMRI. During six scanning episodes (five patients), "power-on" resetting of the device was noted. Magnet-mode pacing was noted during four episodes (three patients). Occasional premature ventricular contractions were noted in one patient. No significant changes in battery voltage, sensed P wave and R wave, pacing thresholds, lead impedance, or cardiac enzymes were noted immediately after MRI or at 1-month follow-up. Conclusions: Overall, no significant changes were seen in pacemaker device function, and no adverse clinical events were observed. A minority of patients with older devices had unpredictable changes in device behavior, which stresses the need for close monitoring during and careful device interrogation after scanning.
AB - Objective: This study aimed to characterize the interactions of pacemakers with magnetic resonance imaging (MRI) and to identify device characteristics that could predict adverse interactions. Background: The safety of MRI in patients with indwelling pacemaker systems remains uncertain. Previous studies demonstrated safety in most patients, but unpredictable, potentially concerning changes in pacemaker behavior have occurred. Methods: We prospectively studied patients with pacemaker devices in situ who were not pacemaker dependent and in whom MRI was essential for adequate diagnosis and treatment. All patients were monitored by electrocardiography and pulse oximetry during scanning; devices were interrogated and cardiac enzymes were measured before and after scanning. Results: Of 32 patients studied (46 MRI examinations), 28 patients had a dual-chamber system and one had a biventricular device. Regions scanned were the head and spine. Devices were reprogrammed to asynchronous pacing or sense-only mode in all except six patients beforeMRI. During six scanning episodes (five patients), "power-on" resetting of the device was noted. Magnet-mode pacing was noted during four episodes (three patients). Occasional premature ventricular contractions were noted in one patient. No significant changes in battery voltage, sensed P wave and R wave, pacing thresholds, lead impedance, or cardiac enzymes were noted immediately after MRI or at 1-month follow-up. Conclusions: Overall, no significant changes were seen in pacemaker device function, and no adverse clinical events were observed. A minority of patients with older devices had unpredictable changes in device behavior, which stresses the need for close monitoring during and careful device interrogation after scanning.
KW - Arrhythmias
KW - Device interactions
KW - Magnetic resonance imaging
KW - Permanent pacemakers
KW - Power-on resetting
UR - https://www.scopus.com/pages/publications/84861703557
UR - https://www.scopus.com/pages/publications/84861703557#tab=citedBy
U2 - 10.1007/s10840-011-9615-8
DO - 10.1007/s10840-011-9615-8
M3 - Article
C2 - 21938517
AN - SCOPUS:84861703557
SN - 1383-875X
VL - 33
SP - 59
EP - 67
JO - Journal of Interventional Cardiac Electrophysiology
JF - Journal of Interventional Cardiac Electrophysiology
IS - 1
ER -